Results 201 to 210 of about 59,855 (258)
Some of the next articles are maybe not open access.
Tardive dyskinesia: Epidemiology.
Journal of Neurological Sciences, 2018The term tardive syndrome (TS) encompasses a few different phenomenologic conditions, some of which occur in isolation and others in association with each other.
A. D'abreu +2 more
semanticscholar +1 more source
Experimental tardive dyskinesia
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1982In this work, we have attempted to reproduce dyskinesia similar to tardive dyskinesia by two methods. In the first experiment, we have administered to 6 macaca mulatta, haloperidol 0.25 mg/kg daily for six months. During that period we observed in all monkeys, after each dose: restlessness, akinesia and tremor.
P J, Bédard, R, Boucher, L, Larochelle
openaire +2 more sources
TARDIVE DYSKINESIA IN THE ELDERLY
Age and Ageing, 1986Four hundred and twenty-six elderly subjects were assessed for the presence of dyskinetic movements. Dyskinetic movements were present in 49 subjects (11.5%). Ninety-two per cent had orofacial movements, by far the commonest being chewing. Dyskinetic movements were present in 12.5% of women and 7.6% of men.
F M, Ramsay, P H, Millard
openaire +2 more sources
Clozapine in tardive dyskinesia
Psychopharmacology, 1978Clozapine, which has had limited clinical testing in the U.S.A., was evaluated in 12 chronic schizophrenic patients with tardive dyskinesia. Its antipsychotic activity was again demonstrated and it suppressed the symptoms of tardive dyskinesia with a marked rebound occurring in these symptoms when it was withdrawn; there was no rigidity or other ...
G M, Simpson, J H, Lee, R K, Shrivastava
openaire +2 more sources
Methylphenidate in Tardive Dyskinesia
American Journal of Psychiatry, 1973Methylphenidate, an amphetamine-like central nervous system (CNS) stimulant used successfully in reversing acute neuroleptic-induced neurological symptoms, was given in a placebo-controlled study to 17 patients with tardive dyskinesia. On global ratings three subjects were improved, six showed an increase in symptoms, and eight showed no changes.
W E, Fann, J M, Davis, I C, Wilson
openaire +2 more sources
Tardive Dyskinesia and Dementia
British Journal of Psychiatry, 1979SummarySeventeen schizophrenic patients with tardive dyskinesia (TD) and 33 schizophrenics without tardive dyskinesia were examined by psychological tests of intellectual function and EMI scans were performed. The group as a whole were found to be demented and 31 out of 45 had abnormalities on the scan.
O O, Famuyiwa +3 more
openaire +2 more sources
TARDIVE DYSKINESIA AND ANTIHISTAMINES
Medical Journal of Australia, 1978A case of tardive dyskinesia due to the prolonged administration of antihistamines is reported. Clinical features are discussed, as well as the alleviation of these by haloperidol.
C, Hale, T, Heins
openaire +2 more sources
Journal of Neurology, 1995
Neuroleptic treatment frequently induces movement disorders, the tardive dyskinesias. These are frequently seen in the orobuccolingual region. Although the beginning of neuroleptic treatment can cause acute dystonia and breathing difficulty, chronic neuroleptic treatment has only rarely been shown to affect the laryngeal musculature. Laryngeal abnormal
A, Fève, B, Angelard, J, Lacau St Guily
openaire +2 more sources
Neuroleptic treatment frequently induces movement disorders, the tardive dyskinesias. These are frequently seen in the orobuccolingual region. Although the beginning of neuroleptic treatment can cause acute dystonia and breathing difficulty, chronic neuroleptic treatment has only rarely been shown to affect the laryngeal musculature. Laryngeal abnormal
A, Fève, B, Angelard, J, Lacau St Guily
openaire +2 more sources
Smoking and tardive dyskinesia
Biological Psychiatry, 1987Boisvert D, Chouinard G (1981): Rebound cardiac arrhythmia after withdrawal from imipramine: A case report. Am J Psych&y 138:985. Brown GM, Stancer HC, Moldofsky H, Harman J, Murphy YT, Gupta RM (1978): Withdrawal from long-term highdose desipramine therapy. Clinical and biological changes. Arch Gen Psychiatry 35:1261.
R L, Binder +3 more
openaire +2 more sources
Quetiapine in tardive dyskinesia
International Journal of Psychiatry in Clinical Practice, 2002Tardive dyskinesia (TD) is a potentially irreversible side-effect of antipsychotic medication. Some atypical antipsychotics, by virtue of their better side-effect profile, seem to have an ability to reverse TD. The importance of trying to treat TD has become more urgent in view of the medico-legal implications of Article 3 of the Human Rights Act, 1998
Suresh, Chari +3 more
openaire +2 more sources